255 related articles for article (PubMed ID: 15993252)
1. COX-dependent mechanisms involved in the antinociceptive action of NSAIDs at central and peripheral sites.
Burian M; Geisslinger G
Pharmacol Ther; 2005 Aug; 107(2):139-54. PubMed ID: 15993252
[TBL] [Abstract][Full Text] [Related]
2. Non-COX-2 targets and cancer: expanding the molecular target repertoire of chemoprevention.
Kashfi K; Rigas B
Biochem Pharmacol; 2005 Oct; 70(7):969-86. PubMed ID: 15949789
[TBL] [Abstract][Full Text] [Related]
3. Effect of cyclooxygenase and NO synthase inhibitors administered centrally on antinociceptive action of acetaminophen (Part II).
Bujalska M
Pol J Pharmacol; 2003; 55(6):1001-11. PubMed ID: 14730095
[TBL] [Abstract][Full Text] [Related]
4. Inhibitors of cyclooxygenases: mechanisms, selectivity and uses.
Botting RM
J Physiol Pharmacol; 2006 Nov; 57 Suppl 5():113-24. PubMed ID: 17218763
[TBL] [Abstract][Full Text] [Related]
5. [Antinociceptive mechanism of action of paracetamol].
Bonnefont J; Courade JP; Alloui A; Eschalier A
Drugs; 2003; 63 Spec No 2():1-4. PubMed ID: 14758785
[TBL] [Abstract][Full Text] [Related]
6. Non-steroidal anti-inflammatory drugs, cyclooxygenase-2 and the bone healing process.
Vuolteenaho K; Moilanen T; Moilanen E
Basic Clin Pharmacol Toxicol; 2008 Jan; 102(1):10-4. PubMed ID: 17973900
[TBL] [Abstract][Full Text] [Related]
7. Pharmacodynamics and pharmacokinetics of nonsteroidal anti-inflammatory drugs in species of veterinary interest.
Lees P; Landoni MF; Giraudel J; Toutain PL
J Vet Pharmacol Ther; 2004 Dec; 27(6):479-90. PubMed ID: 15601442
[TBL] [Abstract][Full Text] [Related]
8. COX-2 inhibition as a tool to treat and prevent colorectal cancer.
Tuynman JB; Peppelenbosch MP; Richel DJ
Crit Rev Oncol Hematol; 2004 Nov; 52(2):81-101. PubMed ID: 15501074
[TBL] [Abstract][Full Text] [Related]
9. Lack of correlation between the central anti-nociceptive and peripheral anti-inflammatory effects of selective COX-2 inhibitor parecoxib.
Urdaneta A; Siso A; Urdaneta B; Cardenas R; Quintero L; Avila R; Suarez-Roca H
Brain Res Bull; 2009 Aug; 80(1-2):56-61. PubMed ID: 19463915
[TBL] [Abstract][Full Text] [Related]
10. COX-2: a molecular target for colorectal cancer prevention.
Brown JR; DuBois RN
J Clin Oncol; 2005 Apr; 23(12):2840-55. PubMed ID: 15837998
[TBL] [Abstract][Full Text] [Related]
11. [The effect of cyclooxygenase inhibitors on the bone and cartilage].
Burdan F
Pol Merkur Lekarski; 2005 Jun; 18(108):709-11. PubMed ID: 16124389
[TBL] [Abstract][Full Text] [Related]
12. Biological interactions between herpesviruses and cyclooxygenase enzymes.
Reynolds AE; Enquist LW
Rev Med Virol; 2006; 16(6):393-403. PubMed ID: 17006962
[TBL] [Abstract][Full Text] [Related]
13. Kinetic modelling of NSAID action on COX-1: focus on in vitro/in vivo aspects and drug combinations.
Goltsov A; Maryashkin A; Swat M; Kosinsky Y; Humphery-Smith I; Demin O; Goryanin I; Lebedeva G
Eur J Pharm Sci; 2009 Jan; 36(1):122-36. PubMed ID: 19028575
[TBL] [Abstract][Full Text] [Related]
14. New insights into COX-2 biology and inhibition.
Patrignani P; Tacconelli S; Sciulli MG; Capone ML
Brain Res Brain Res Rev; 2005 Apr; 48(2):352-9. PubMed ID: 15850674
[TBL] [Abstract][Full Text] [Related]
15. [Cyclooxygenases in the spinal cord and the relationship with pain].
Li SQ; Li WB
Sheng Li Ke Xue Jin Zhan; 2003 Oct; 34(4):359-60. PubMed ID: 14992024
[No Abstract] [Full Text] [Related]
16. Effects of cyclooxygenase inhibition on the gastrointestinal tract.
Radi ZA; Khan NK
Exp Toxicol Pathol; 2006 Nov; 58(2-3):163-73. PubMed ID: 16859903
[TBL] [Abstract][Full Text] [Related]
17. Prostaglandins and cyclooxygenases [correction of cycloxygenases] in the spinal cord.
Vanegas H; Schaible HG
Prog Neurobiol; 2001 Jul; 64(4):327-63. PubMed ID: 11275357
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of both COX-1 and COX-2 and resulting decrease in the level of prostaglandins E2 is responsible for non-steroidal anti-inflammatory drug (NSAID)-dependent exacerbation of colitis.
Tanaka K; Suemasu S; Ishihara T; Tasaka Y; Arai Y; Mizushima T
Eur J Pharmacol; 2009 Jan; 603(1-3):120-32. PubMed ID: 19101538
[TBL] [Abstract][Full Text] [Related]
19. Iloprost-induced nociception: determination of the site of anti-nociceptive action of cyclooxygenase inhibitors and the involvement of cyclooxygenase products in central mechanisms of nociception.
Ayoub SS; Botting RM
Methods Mol Biol; 2010; 644():207-15. PubMed ID: 20645177
[TBL] [Abstract][Full Text] [Related]
20. The involvement of a cyclooxygenase 1 gene-derived protein in the antinociceptive action of paracetamol in mice.
Ayoub SS; Colville-Nash PR; Willoughby DA; Botting RM
Eur J Pharmacol; 2006 May; 538(1-3):57-65. PubMed ID: 16674937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
